 |
|
 |
|
|
Vancouver, Canada, November 7 (ots/PRNewswire) - Burcon
NutraScience Corporation (TSX-V: BU) announced today that it has
recently entered into a number of additional three-way material
transfer agreements ("MTA's") enabling the provision of samples of
Burcon's proteins, Puratein(R) and Supertein(TM), to third parties
for testing while protecting certain intellectual property interests
of all of the parties involved. The recipients of the protein
samples include certain globally recognized food and beverage
companies as well as companies involved in the fields of consumer
nutritional products and medical nutrition products.
The economic value of protein ingredients derives from two major
attributes: function and nutrition. Functionally, Burcon's
Puratein(R) and Supertein(TM) demonstrate potential to replace egg,
dairy and other proteins in a number of broad applications such as
emulsifying, gelling, and binding. Additionally, Supertein's unique
solubility profile suggests potential for its use in beverages -
particularly low pH beverages - where traditional protein
ingredients experience challenges. Nutritionally, Burcon's proteins
also exhibit exciting potential for use in nutritional supplements,
sports beverages and medical nutrition products.
The purpose of the MTA's which are the subject of this
announcement and the MTA's previously announced, is to provide
samples of Burcon's proteins to the major potential end users in
order that they may test the proteins in food matrices, beverages,
nutritional products etc.
As previously reported, material transfer agreements are contracts
that govern the transfer of tangible research materials between two
or more organizations, when the recipient intends to use the
materials for its own research purposes. The MTA's that are the
subject of this announcement are three-way contracts among Burcon,
Archer Daniels Midland ("ADM") and certain major food and beverage
companies. These MTA's define the rights and obligations of Burcon
and ADM, but just as importantly they define the rights and
obligations of the food and beverage companies who are the recipient
with respect to the proteins and any derivatives thereof. The rights
defined include intellectual property issues, confidentiality terms
and matters governing the publication of findings.
"We have continued to focus our efforts on getting Puratein(R) and
Supertein(TM) into the new product innovation centers of the major
food and beverage companies so that they can test-drive them in their
products," stated Johann F. Tergesen, Burcon's President & COO, who
added, "We look forward to working with these potential partners in
creating opportunities and applications for our proteins."
Discussions among Burcon, ADM and food and beverage companies are
ongoing and it is anticipated that additional three-way MTA's will be
entered into in the future.
About Burcon NutraScience
Burcon is a research and development company developing a
portfolio of composition, application, and process patents around its
plant protein extraction and purification technology. The goal of
Burcon's research is to develop its patented process to utilize
inexpensive oilseed meals for the production of purified plant
proteins that exhibit valuable nutritional, functional or
nutraceutical profiles. Burcon, in conjunction with Archer Daniels
Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM).
Canola, recognized for its nutritional qualities, is the
second-largest oilseed crop in the world after soybeans. Burcon's
goal is to develop Puratein and Supertein to participate with soy,
dairy, and egg proteins in the expanding multi-billion-dollar protein
ingredient market, with potential uses in prepared foods, nutritional
supplements, and personal care products.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements that involve risks and uncertainties. These
forward-looking statements relate to, among other things, plans and
timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in
this press release that are not historical fact. Our expectations
regarding the prospect for future success depend upon our ability to
develop and sell products, which we do not produce today and cannot
be sold without further research and development. When used in this
press release, the words "goal", "intend", "believes" and "potential"
and similar expressions, generally identify forward-looking
statements. These statements reflect our current expectations. They
are subject to a number of risks and uncertainties. In light of the
many risks and uncertainties surrounding the development of a source
of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this
press release will be realized.
ots Originaltext: Burcon NutraScience Corporation
Im Internet recherchierbar: http://www.presseportal.de
Contact:
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896, +1-888-408-7960 toll-free,
jcheng@burcon.ca, www.burcon.ca; AXINO AG, Sven Olsson, Investor
Relations Germany, Silberburgstrasse 112, D-70176 Stuttgart, Germany,
Tel. +49-711-25-35-92-30, Fax +49-711-25-35-92-33, olsson@axino.de,
www.burcon.net
|
| |
 |
|
 |
| |
 |
Login |
 |
|
|
Themen-Infos |
|
|
|
Artikel Bewertung |
|
|
 |
durchschnittliche Punktzahl: 0
Stimmen: 0
|
|
|
|
